Exchange: NASDAQ·Updated 07:30 PM EDT
SUPN logo

SUPN Supernus Pharmaceuticals Inc

$43.74
$0.47
(1.06%)
Today
Closed $43.74
$0.00
(0.00%)
After Hours
Reported EarningsAug 3
Mkt Cap$2.57B
Vol757,781.00

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.
45

Neutral Sentiment

How do you feel about SUPN?

Advertisement|Remove ads.